You have 9 free searches left this month | for more free features.

metastatic intraocular melanoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

Active, not recruiting
  • Tumor Skin
  • +2 more
  • OBX-115
  • Orlando, Florida
  • +1 more
Sep 28, 2023

Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)

Completed
  • Intraocular Melanoma
  • +2 more
  • Santa Monica, California
  • +11 more
Jun 15, 2021

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Uveal Melanoma, Uveal Melanoma, Posterior, Medium/Large Size, Eye Cancer, Intraocular Melanoma Trial in Stockholm (Melatonin)

Not yet recruiting
  • Uveal Melanoma
  • +2 more
  • Stockholm, Sweden
    St. Erik Eye Hospital
Aug 14, 2022

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Immunotherapy in Patients With Metastatic Melanoma

Not yet recruiting
  • Metastatic Melanoma
  • data collection
  • (no location specified)
Nov 28, 2022

Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Iris Melanoma Trial in

Completed
  • Ciliary Body and Choroid Melanoma, Medium/Large Size
  • +5 more
  • Cixutumumab
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
  • +1 more
Feb 5, 2020

Healthcare Resource Utilization and Costs in Metastatic Melanoma

Terminated
  • Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Apr 27, 2023

    Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

    Not yet recruiting
    • Metastatic Melanoma
    • Head and Neck Squamous Cell Carcinoma
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 19, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

    Not yet recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Feb 28, 2023

    Uveal Melanoma Trial in Nice, Paris (Supportive care visit with questionnaires, Oncological standard visit)

    Recruiting
    • Uveal Melanoma
    • Supportive care visit with questionnaires
    • Oncological standard visit
    • Nice, France
    • +1 more
    Jan 19, 2023

    Baseline Metastases on Clinical Outcomes Among BRAF Positive

    Completed
    • BRAF Positive Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis
      Aug 2, 2023

      Melanoma Trial in Beijing City, Fuzhou City, Zhejiang (Atezolizumab, Bevacizumab)

      Active, not recruiting
      • Melanoma
      • Beijing City, China
      • +2 more
      Dec 13, 2022

      Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

      Not yet recruiting
      • Advanced Melanoma
      • Metastatic Melanoma
      • Memory-like natural killer cells
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 16, 2022

      Associated Factors, and Clinical Outcomes of Prescribing

      Completed
      • BRAF v600 Mutated Metastatic Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Mar 28, 2023

        Definity for Ultrasound of Intraocular Tumors

        Withdrawn
        • Ocular Melanoma
          • Atlanta, Georgia
            Emory Eye Center
          Feb 7, 2022

          Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

          Recruiting
          • Clinical Stage III Cutaneous Melanoma AJCC v8
          • +9 more
          • Biospecimen Collection
          • Electronic Health Record Review
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Oct 4, 2023

          Metastatic Melanoma Trial in Marseille (PET with 18F-FDOPA)

          Completed
          • Metastatic Melanoma
          • PET with 18F-FDOPA
          • Marseille, France
            Assistance Publique Hopitaux de Marseille
          Nov 9, 2022

          Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

          Not yet recruiting
          • Metastatic Melanoma
          • +2 more
          • Lifileucel plus Pembrolizumab
          • Pembrolizumab with Optional Crossover Period
          • (no location specified)
          Feb 13, 2023

          Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester

          Not yet recruiting
          • Clinical Stage IV Cutaneous Melanoma AJCC v8
          • +4 more
          • Aerosol Sargramostim
          • +5 more
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Jan 30, 2023